173 related articles for article (PubMed ID: 34046336)
1. The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer.
Apanovich N; Apanovich P; Mansorunov D; Kuzevanova A; Matveev V; Karpukhin A
Front Oncol; 2021; 11():615787. PubMed ID: 34046336
[TBL] [Abstract][Full Text] [Related]
2. The Genes-Candidates for Prognostic Markers of Metastasis by Expression Level in Clear Cell Renal Cell Cancer.
Apanovich N; Peters M; Apanovich P; Mansorunov D; Markova A; Matveev V; Karpukhin A
Diagnostics (Basel); 2020 Jan; 10(1):. PubMed ID: 31936274
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Distant Metastases in Patients with Kidney Cancer Based on Gene Expression and Methylation Analysis.
Apanovich N; Matveev A; Ivanova N; Burdennyy A; Apanovich P; Pronina I; Filippova E; Kazubskaya T; Loginov V; Braga E; Alimov A
Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443682
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma.
Laursen KB; Chen Q; Khani F; Attarwala N; Gross SS; Dow L; Nanus DM; Gudas LJ
Front Oncol; 2021; 11():783856. PubMed ID: 34970493
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
6. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
[TBL] [Abstract][Full Text] [Related]
7. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
Front Physiol; 2018; 9():399. PubMed ID: 29720944
[TBL] [Abstract][Full Text] [Related]
8. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
9. Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.
Minton DR; Fu L; Mongan NP; Shevchuk MM; Nanus DM; Gudas LJ
Clin Cancer Res; 2016 Jun; 22(11):2791-801. PubMed ID: 26783287
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
11. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
12. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Reustle A; Di Marco M; Meyerhoff C; Nelde A; Walz JS; Winter S; Kandabarau S; Büttner F; Haag M; Backert L; Kowalewski DJ; Rausch S; Hennenlotter J; Stühler V; Scharpf M; Fend F; Stenzl A; Rammensee HG; Bedke J; Stevanović S; Schwab M; Schaeffeler E
Genome Med; 2020 Mar; 12(1):32. PubMed ID: 32228647
[TBL] [Abstract][Full Text] [Related]
13. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
14. Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Zhang Y; Chen M; Liu M; Xu Y; Wu G
Oxid Med Cell Longev; 2021; 2021():6699808. PubMed ID: 33564363
[TBL] [Abstract][Full Text] [Related]
15. Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.
Lobo NC; Gedye C; Apostoli AJ; Brown KR; Paterson J; Stickle N; Robinette M; Fleshner N; Hamilton RJ; Kulkarni G; Zlotta A; Evans A; Finelli A; Moffat J; Jewett MA; Ailles L
BMC Cancer; 2016 Jul; 16():485. PubMed ID: 27422173
[TBL] [Abstract][Full Text] [Related]
16. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
17. Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma.
Xu W; Hu X; Anwaier A; Wang J; Liu W; Tian X; Zhu W; Ma C; Wan F; Shi G; Qu YY; Zhang H; Ye D
Front Mol Biosci; 2020; 7():610229. PubMed ID: 33569391
[No Abstract] [Full Text] [Related]
18. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma.
Lucarelli G; Rutigliano M; Sallustio F; Ribatti D; Giglio A; Lepore Signorile M; Grossi V; Sanese P; Napoli A; Maiorano E; Bianchi C; Perego RA; Ferro M; Ranieri E; Serino G; Bell LN; Ditonno P; Simone C; Battaglia M
Aging (Albany NY); 2018 Dec; 10(12):3957-3985. PubMed ID: 30538212
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]